dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
sarpin 10 mg + 160 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - amlodipinum + valsartanum - tabletki powlekane - 10 mg + 160 mg
simdax 2,5 mg/ml koncentrat do sporządzania roztworu do infuzji
orion corporation - lewozymendan - koncentrat do sporządzania roztworu do infuzji - 2,5 mg/ml
symezet 10 mg tabletki
symphar sp. z o.o. - ezetimibum - tabletki - 10 mg
mizetib 10 mg tabletki
zakłady farmaceutyczne polpharma s.a. - ezetimibum - tabletki - 10 mg
grumabix 500 mg tabletki powlekane
adamed pharma s.a. - abirateroni acetas - tabletki powlekane - 500 mg
grumabix 250 mg tabletki powlekane
adamed pharma s.a. - abirateroni acetas - tabletki powlekane - 250 mg
levosimendan kalceks 2,5 mg/ml koncentrat do sporządzania roztworu do infuzji
as kalceks - lewozymendan - koncentrat do sporządzania roztworu do infuzji - 2,5 mg/ml
levosimendan accord 2,5 mg/ml koncentrat do sporządzania roztworu do infuzji
accord healthcare polska sp. z o.o. - levosimendanum - koncentrat do sporządzania roztworu do infuzji - 2,5 mg/ml